Overview

Target Engagement of Terazosin in Healthy Adults

Status:
Recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the target engagement of Terazosin (TZ) in a single cohort of 6 healthy adult participants. During the study participants will undergo PET/CT scans, 7-Tesla MRI scans, blood draws, and an optional lumbar puncture (LP.)
Phase:
Phase 1
Details
Lead Sponsor:
University of Iowa
Collaborator:
Michael J. Fox Foundation for Parkinson's Research
Treatments:
Terazosin